Pharma-Bio Serv (PBSV) Net Income towards Common Stockholders (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Net Income towards Common Stockholders came in at $232986.0 in Q2 2026, up 144.34% YoY from $95353.0 in Q2 2025, and up 609.03% on a QoQ basis from $32860.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has 17 years of Net Income towards Common Stockholders data on file, last reported at $232986.0 in Q2 2026.
- Quarterly Net Income towards Common Stockholders rose 144.34% year-over-year to $232986.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $51936.0 (up 127.45% YoY) and the FY2025 annual result came in at -$100463.0, up 87.08% from the prior year.
- Net Income towards Common Stockholders climbed to $232986.0 in Q2 2026, from $32860.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $526242.0 in Q3 2023 to a low of -$309194.0 in Q3 2024.
- A 5-year average of $94170.6 and a median of $64106.5 in 2025 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders tumbled 163.48% — and 2026, when it jumped 284.96%.
- Tracing PBSV's Net Income towards Common Stockholders over 5 years: stood at $173379.0 in 2022, then slumped by 127.19% to -$47148.0 in 2023, then jumped by 134.17% to $16111.0 in 2024, then tumbled by 100.63% to -$102.0 in 2025, then surged by 228517.65% to $232986.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at $232986.0 (Q2 2026), $32860.0 (Q1 2026), and -$102.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 84.30 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 69.42 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -17.93 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 43.10 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 40.87 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 24.32 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -15.74 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 232,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 232,986.00 |
| Jan 31, 2026 | 32,860.00 |
| Oct 31, 2025 | -102.00 |
| Jul 31, 2025 | -213,808.00 |
| Apr 30, 2025 | 95,353.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | 16,111.00 |
| Jul 31, 2024 | -309,194.00 |
| Apr 30, 2024 | -213,817.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -47,148.00 |
| Jul 31, 2023 | 526,242.00 |
| Apr 30, 2023 | 404,654.00 |
| Jan 31, 2023 | 426,432.00 |
| Oct 31, 2022 | 173,379.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |